Lung cancer CAFs produce inflammatory mediators such as interleukin (IL)-6, IL-8, IL-17, IL-22, tumor necrosis factor (TNF)-α, and vascular endothelial growth factor (VEGF) to support progression, invasion, and angiogenesis. Here, VEGFA is linked to lung cancer.